QualityStocksNewsBreaks Archives

ThursdayJun 18, 2026 1:01 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Positions AI Voice Analysis as Scalable Testing Alternative

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) was featured in a recent TechMediaWire Podcast, where CEO Justin Hanka discussed the company’s plans to commercialize AI-powered voice analysis technology designed to detect alcohol and drug intoxication through non-invasive speech assessment. During the interview, Hanka explained that the company has built prediction models using more than 50 million data points collected through years of clinical research, enabling the identification of intoxication indicators associated with alcohol and drug use. MindBio believes its technology offers a scalable alternative to traditional testing methods that…

ThursdayJun 18, 2026 12:29 pm

QualityStocksNewsBreaks – Why Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Is ‘One to Watch’

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. A clinical-stage oncology company , Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is focused on advancing a new class of DNA Damage Response (“DDR”) therapies and developing artificial intelligence-driven precision oncology solutions. “The company is leading the development of Polynucleotide Kinase Phosphatase (‘PNKP’) inhibitors, an emerging category of DDR therapeutics designed to target DNA repair pathways involved in cancer survival and resistance,” reads a recent article. “Through its dual-platform approach, Onco-Innovations combines proprietary drug development with AI-enabled technologies intended to support oncology research, clinical development, patient stratification and evidence generation.” To…

ThursdayJun 18, 2026 11:44 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Receives Delivery of 5MW Pre-Production Texatron™ Fusion Engine™

American Fusion (OTC: AMFN) announced that members of its engineering and leadership teams have arrived in Texas to accept delivery of the company's 5MW Pre-Production Texatron™ Fusion Engine™, a milestone that follows the completion of final fabrication and modification activities. The system is expected to be transported to the Dallas-Fort Worth Metroplex, where installation, commissioning and testing activities are planned as the company advances development of its proprietary aneutronic fusion technology. American Fusion said the 5MW pre-production system represents the culmination of nine prototype generations and is expected to serve as the primary platform for future testing, validation and development efforts. The company also noted that…

ThursdayJun 18, 2026 10:10 am

QualityStocksNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Reports Fiscal 2026 Revenue Growth, Higher Earnings

Earth Science Tech (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, highlighted by revenue of $35.7 million, up 8% from the prior year, gross profit of $25.5 million, up 5%, and net income of $3.6 million, an 11% increase compared with fiscal 2025. Total assets rose 27% year over year to $9.0 million as the company continued expanding its integrated healthcare platform across telemedicine, pharmacy and fulfillment services. The company also emphasized its capital allocation strategy, noting it repurchased and retired more than 4 million shares during fiscal 2026 and more than 7.1 million shares…

ThursdayJun 18, 2026 10:00 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Engages Tetra Tech, GeoSim for Sarfartoq S-K 1300 Resource Update

Greenland Mines (NASDAQ: GRML) announced the engagement of Tetra Tech Canada Inc. and GeoSim Services Inc. to prepare an updated SEC S-K 1300-compliant mineral resource estimate for its Sarfartoq neodymium-praseodymium rare earth project in southwest Greenland. The updated resource estimate, expected to be substantially completed this summer, will incorporate historical NI 43-101 resource work along with drilling and technical studies completed by Neo Performance Materials between 2023 and 2025, and is intended to support an updated preliminary economic assessment and future development studies. GeoSim, led by Ronald G. Simpson, P.Geo., has been appointed as the qualified person for the resource…

ThursdayJun 18, 2026 9:41 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform

VERAXA Biotech (NASDAQ: VRXA) announced new in vitro proof-of-concept data supporting its novel BiTAC(TM)-ADC technology platform, which is designed to improve precision in cancer treatment through tumor-restricted activation of therapeutic agents. The company reported that BiTAC-ADCs demonstrated the ability to distinguish between breast cancer and healthy cells and achieved dose-dependent killing of 3D tumor cell spheroids while minimizing toxicity through the use of separately delivered, systemically inactive precursor components. VERAXA said the findings further validate the potential of its BiTAC-ADC platform and complement its BiTAC-TCE technology, providing the company with two differentiated cancer therapy platforms that may be applicable across multiple solid tumor indications. Management plans to discuss partnering opportunities for…

ThursdayJun 18, 2026 9:20 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in AINewsWire Editorial on AI Infrastructure Automation Opportunity

Nightfood Holdings (OTCQB: NGTF) announced its placement in an AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is driving demand for automation and robotics solutions across multiple industries. The article highlights the massive capital investment flowing into AI data centers, semiconductor production and related infrastructure, while noting that physical construction, power deployment and operational support have emerged as key constraints on future growth. The editorial also discusses Nightfood's TechForce Robotics division and its recently announced partnership with JJ Enterprise to advance AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics. According to the feature, the collaboration positions TechForce…

ThursdayJun 18, 2026 9:00 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Launches AI-Powered GMP Manufacturing Services Platform at BIO 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced the launch of its artificial intelligence-powered good manufacturing practices manufacturing services platform at the 2026 BIO International Convention in San Diego. The platform combines the company's PDAOAI™ technology with advanced robotics provided through its collaboration with TechForce Robotics to support pharmaceutical, biotechnology and advanced therapeutics companies seeking to modernize manufacturing operations through AI-driven workflows, digital quality systems and intelligent automation. Oncotelic said the platform is designed to support electronic batch records, manufacturing documentation, GMP workflow digitization, quality and compliance functions and process monitoring. The company will also showcase progress with its Deciparticle™ nanomedicine platform, including…

WednesdayJun 17, 2026 3:26 pm

QualityStocksNewsBreaks – Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine

Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. “Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur,” reads a recent article. “The company’s vision reflects a broader shift taking place across the healthcare industry toward predictive and precision medicine. Cardio Diagnostics envisions a healthcare system where every patient receives individualized care informed by their unique molecular insights and where heart disease is no longer the world’s leading killer. Achieving that goal…

WednesdayJun 17, 2026 2:02 pm

QualityStocksNewsBreaks – Why Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) Is ‘One to Watch’

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) develops AI-powered platforms focused on accelerating chemistry research and development across pharmaceutical, defense, public safety, and industrial applications. “The company is working at the intersection of AI and chemistry, building tools intended to help organizations navigate increasingly complex scientific and development challenges,” reads a recent article. “Redwood AI’s platforms are built on proprietary AI models and analytical infrastructure that improve as datasets and platform usage expand.” To view the full article, visit https://ibn.fm/1uqAl About Redwood AI Corp. Redwood AI uses advanced artificial…

Site Search

Company Search

Category: QualityStocksNewsBreaks